<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="publisher-id">CI</journal-id><journal-id journal-id-type="publisher-id">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>e-Med</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17921087</article-id><article-id pub-id-type="pmc">2727968</article-id><article-id pub-id-type="publisher-id">ci079010</article-id><article-id pub-id-type="doi">10.1102/1470-7330.2007.9010</article-id><article-categories><subj-group subj-group-type="heading"><subject>Focus on: Pancreatic Neoplasms</subject></subj-group><series-title>Focus on: Pancreatic Neoplasms</series-title></article-categories><title-group><article-title>Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Francis</surname><given-names>Isaac R.</given-names></name></contrib></contrib-group><aff>University of Michigan Hospitals, Ann Arbor, MI 48109-0030, USA</aff><author-notes><corresp><italic>Corresponding address: Isaac R. Francis, MD, Department of Radiology, University of Michigan Health System, 1500 E. Medical Center, Ann Arbor, MI48109-0030, USA. Email</italic>: <email>ifrancis@umich.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>1</day><month>10</month><year>2007</year></pub-date><volume>7</volume><issue>Special issue A</issue><fpage>S160</fpage><lpage>S165</lpage><permissions><copyright-statement>&#x000a9; 2007 International Cancer Imaging Society</copyright-statement></permissions><abstract><title>Abstract</title><p>Pancreatic adenocarcinoma continues to be a leading cause of cancer death in the Western world and is amongst the leading gastrointestinal cancers. The incidence of pancreatic cancer has been stable or slowly rising in the past few decades. Overall the prognosis is poor with 5-year survival rates still under 5%. Therefore early detection and accurate staging of these tumors is crucial for optimal treatment.</p></abstract><kwd-group><kwd>Pancreatic adenocarcinoma</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Pancreatic adenocarcinoma continues to be a leading cause of cancer death in the Western world and is amongst the leading gastrointestinal cancers. The incidence of pancreatic cancer has been stable or slowly rising in the past few decades. Overall the prognosis is poor with 5-year survival rates still under 5%. Therefore early detection and accurate staging of these tumors is crucial for optimal treatment.</p><p>Pancreatic adenocarcinoma is the most common pancreatic exocrine neoplasm and accounts for 75&#x02013;85% of all pancreatic malignancies. Common etiologies implicated are cigarette smoking, chronic pancreatitis and hereditary chronic pancreatitis<sup>[<xref ref-type="bibr" rid="B1 B2 B3 B4 B5 B6">1&#x02013;6</xref>]</sup>.</p><p>The majority of the tumors are located in the head of the pancreas<sup>[<xref ref-type="bibr" rid="B7">7,</xref><xref ref-type="bibr" rid="B8">8</xref>]</sup>. Tumors located in the pancreatic head can obstruct the common bile duct leading to jaundice and tend therefore to be detected earlier, compared to tumors located in the body and tail which usually present in the late stages of the disease, often with distant metastases or locally advanced disease. However most tumors present late with advanced stages of the disease and so curative resection is possible only in about 10&#x02013;15% of patients<sup>[<xref ref-type="bibr" rid="B1 B2 B3 B4 B5 B6">1&#x02013;6</xref>]</sup>. Therefore accurate staging is essential to differentiate the resectable patient from the unresectable and imaging plays a critical role in making this differentiation.</p><p>Contraindications to curative resection are the presence of liver or other distant metastases, peritoneal metastases, greater than half circumferential encasement of major mesenteric vascular structures (celiac, hepatic, superior mesenteric artery), and local infiltration into the peripancreatic fat, and mesentery of the jejunum or transverse mesocolon<sup>[<xref ref-type="bibr" rid="B6">6</xref>]</sup>. Mesenteric venous encasement (superior mesenteric vein and portal vein) is a relative contraindication for resection, as at some centers, en-bloc resection of tumor and the involved vein is performed with placement of a graft.</p></sec><sec><title>Imaging</title><p>While ultrasonography (US), computed tomography (CT) and magnetic resonance imaging (MRI) can all be used in the detection and staging of pancreatic carcinoma, CT is probably the most common modality used. As CT is the main diagnostic technique used in our center for the detection and staging of pancreatic carcinoma, the following discussion focuses on the use of multidetector-row computed tomography (MDCT).</p><sec><title>MDCT</title><p>MDCT enables evaluation of the pancreas during various phases of parenchymal enhancement during intravenous contrast administration. Several studies have shown that biphasic imaging of the pancreas is helpful in the detection and staging of pancreatic carcinoma and that the tumor-to-parenchymal differences are maximized during the pancreatic parenchymal phase of contrast enhancement<sup>[<xref ref-type="bibr" rid="B9">9,</xref><xref ref-type="bibr" rid="B10">10</xref>]</sup> (<xref ref-type="fig" rid="F1">Fig. 1</xref>a,b). Using a 64-detector MDCT, we perform a biphasic protocol consisting of thin section (0.625&#x02009;mm collimation) images obtained during the pancreatic parenchymal phase (50&#x02009;s following commencement of intravenous contrast administration) followed by a hepatic parenchymal or portal venous phase at 65&#x02009;s. A total of 125&#x02009;ml of iodinated intravenous contrast (concentration 370&#x02009;mg/ml of iodine) is injected at 4&#x02013;5&#x02009;ml/s followed by a 50&#x02009;ml saline flush. Negative oral contrast is used to delineate and distend the stomach and duodenum permitting the rendering of 3D images (<xref ref-type="fig" rid="F2">Fig. 2</xref>).
<fig id="F1" position="float"><label><italic>Figure 1</italic></label><caption><p><bold>Contrast-enhanced axial CT images in pancreatic parenchymal (a) and portal venous phases of enhancement (b). Note the tumor (arrow) is best seen in the pancreatic parenchymal phase (a).</bold></p></caption><graphic xlink:href="ci07901001"/></fig>
<fig id="F2" position="float"><label><italic>Figure 2</italic></label><caption><p><bold>Curved planar reformatted CT image through the pancreatic duct shows the relationship of the tumor (arrow) to the pancreatic duct.</bold></p></caption><graphic xlink:href="ci07901002"/></fig></p><p>The thin-section images obtained with this technique are sent to the 3D laboratory for image processing and reformatting (curved planar, coronal and sagittal images) (<xref ref-type="fig" rid="F3">Fig. 3</xref>)<sup>[<xref ref-type="bibr" rid="B11 B12 B13 B14 B15">11&#x02013;15</xref>]</sup>. Some recent studies have shown that these 3D images may be more accurate in staging<sup>[<xref ref-type="bibr" rid="B13">13</xref>]</sup>.
<fig id="F3" position="float"><label><italic>Figure 3</italic></label><caption><p><bold>Coronal reformatted CT image depicts dilated pancreatic duct (arrowhead) due to obstructing tumor (arrow) in the pancreatic head.</bold></p></caption><graphic xlink:href="ci07901003"/></fig></p><p>Most often pancreatic adenocarcinomas are seen as hypoattenuating masses. Rarely they can be isodense to the normal pancreatic parenchyma, and difficult to detect. In these situations, indirect signs such as &#x02018;upstream&#x02019; pancreatic duct dilation or the &#x02018;double duct&#x02019; sign due to pancreatic and common bile duct obstruction are helpful to diagnose the small isoattenuating tumors.</p><p>The overall sensitivity for tumor detection by MDCT has been reported to be between 76 and 92%, but drops to between 63% and 77% when small tumors &#x0003c;2&#x02009;cm in size are included in the analysis<sup>[<xref ref-type="bibr" rid="B5 B6 B7 B10 B15 B16 B17">5&#x02013;7</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B15 B16 B17">15&#x02013;17</xref>]</sup>. The use of multiplanar reconstructions has improved the detection especially of small tumors<sup>[<xref ref-type="bibr" rid="B12 B13 B14">12&#x02013;14</xref>]</sup>.</p></sec><sec><title>MRI</title><p>Breath-hold sequences such as axial two dimensional (2D) spoiled gradient-recalled (SPGR), axial T1 spin echo (SE) with fat saturation, and axial three-dimensional (3D) gadolinium-enhanced SPGR images are combined with coronal single shot fast spin echo (SSFSE), and axial T2 fat saturated FSE images to provide excellent visualization of the pancreas and the adjacent structures thereby providing images that can detect, characterize and stage pancreatic carcinoma. Magnetic resonance cholangiopancreatography (MRCP) can be used in conjunction with pancreatic MRI for depiction of the pancreatico-biliary system<sup>[<xref ref-type="bibr" rid="B18 B19 B20 B21 B22 B23 B24 B25">18&#x02013;25</xref>]</sup>.</p><p>Most pancreatic carcinomas are seen as hypointense tumors compared to the normal pancreas on T1-weighted fat suppressed images, and as hypointense lesions on arterial phase gadolinium-enhanced images (<xref ref-type="fig" rid="F4">Fig. 4</xref>), but can show progressive enhancement on delayed scans.</p><p>Most studies comparing MDCT and MRI for the detection and staging of pancreatic carcinoma have shown that both studies have similar accuracy, although recent studies have shown sight superiority for MDCT, in part due to the recent technical improvements in MDCT<sup>[<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</sup>.
<fig id="F4" position="float"><label><italic>Figure 4</italic></label><caption><p><bold>Axial contrast-enhanced spoiled gradient-echo 3D MR image depicts a tumor in the pancreatic body as a hypointense mass (arrow) relative to the enhancing normal pancreatic parenchyma.</bold></p></caption><graphic xlink:href="ci07901004"/></fig></p></sec><sec><title>Endoscopic ultrasound</title><p>MDCT is inferior to endoscopic ultrasound (EUS) especially in the detection of small tumors. A recent study by DeWitt has shown that EUS had a sensitivity of 98% compared to 86% for MDCT<sup>[<xref ref-type="bibr" rid="B26">26</xref>]</sup>. EUS has also been shown to have a high negative predictive value for excluding pancreatic cancer, and may therefore play a role in screening for pancreatic malignancies<sup>[<xref ref-type="bibr" rid="B27">27,</xref><xref ref-type="bibr" rid="B28">28</xref>]</sup>.</p></sec></sec><sec><title>Staging</title><p>Although TNM staging is not widely used by radiologists, oncologists do use this staging system<sup>[<xref ref-type="bibr" rid="B29">29</xref>]</sup> (<xref ref-type="table" rid="T1">Table 1</xref>). T stage is defined by tumor size, and local spread of the tumor, with T1 tumors being &#x0003c;2&#x02009;cm in size and confined to the pancreas, with T2 tumors being &#x0003e;2&#x02009;cm in size but still confined to the pancreas (<xref ref-type="fig" rid="F5">Fig. 5</xref>). Tumor infiltration into the common bile duct, duodenum or peripancreatic tissues without associated major peripancreatic vascular infiltration is defined as T3 (<xref ref-type="fig" rid="F6">Fig. 6</xref>); infiltration into the major peripancreatic vessels and contiguous organs such as the spleen, stomach or transverse colon is defined as T4. N stage is dependent on the presence of nodal metastasis, with N1 representing peripancreatic nodal metastases. Metastasis to more distant nodes such as para-aortic nodes is defined as M1 disease. Other sites of distant metastases are the liver and peritoneum.
<fig id="F5" position="float"><label><italic>Figure 5</italic></label><caption><p><bold>Axial contrast-enhanced CT image shows a pancreatic head tumor measuring &#x0003e;2&#x02009;cm (arrow) but still confined to the pancreatic parenchyma, representing a T2 tumor.</bold></p></caption><graphic xlink:href="ci07901005"/></fig>
<fig id="F6" position="float"><label><italic>Figure 6</italic></label><caption><p><bold>Contrast-enhanced axial CT image shows a mass in the body of the pancreas with peripancreatic invasion (arrows).</bold></p></caption><graphic xlink:href="ci07901006"/></fig>
<table-wrap id="T1" position="float"><label><italic>Table 1</italic></label><caption><p><bold><italic>TNM staging of pancreatic carcinoma</italic></bold></p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Stage</th><th rowspan="1" colspan="1">Definition</th></tr></thead><tbody align="left"><tr><td colspan="2" rowspan="1"><italic>Primary tumor</italic></td></tr><tr><td rowspan="1" colspan="1">Tis</td><td rowspan="1" colspan="1">Carcinoma in situ</td></tr><tr><td rowspan="1" colspan="1">T1</td><td rowspan="1" colspan="1">Tumor limited to pancreas, &#x02264;2&#x02009;cm in any direction</td></tr><tr><td rowspan="1" colspan="1">T2</td><td rowspan="1" colspan="1">Tumor limited to pancreas, &#x02265;2&#x02009;cm in any direction</td></tr><tr><td rowspan="1" colspan="1">T3</td><td rowspan="1" colspan="1">Infiltration into peripancreatic tissue, duodenum and/or common bile duct</td></tr><tr><td rowspan="1" colspan="1">T4</td><td rowspan="1" colspan="1">Infiltration into peripancreatic vessels, stomach, spleen, large bowel</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="2" rowspan="1"><italic>Regional lymph nodes</italic></td></tr><tr><td rowspan="1" colspan="1">N0</td><td rowspan="1" colspan="1">No lymph node metastases</td></tr><tr><td rowspan="1" colspan="1">N1</td><td rowspan="1" colspan="1">Metastasis in peripancreatic lymph nodes</td></tr><tr><td rowspan="1" colspan="1">Nx</td><td rowspan="1" colspan="1">Unknown</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="2" rowspan="1"><italic>Distant metastases</italic></td></tr><tr><td rowspan="1" colspan="1">M0</td><td rowspan="1" colspan="1">No distant metastases</td></tr><tr><td rowspan="1" colspan="1">M1</td><td rowspan="1" colspan="1">Distant metastases present</td></tr><tr><td rowspan="1" colspan="1">Mx</td><td rowspan="1" colspan="1">Unknown</td></tr></tbody></table><table-wrap-foot><fn><p>Adapted from ref. [29].</p></fn></table-wrap-foot></table-wrap></p><p>While both MDCT and MRI are reasonably accurate in detecting local spread and distant visceral metastases<xref ref-type="bibr" rid="B1">1,</xref><xref ref-type="bibr" rid="B2">2,</xref><xref ref-type="bibr" rid="B6">6,</xref><xref ref-type="bibr" rid="B7">7,</xref><xref ref-type="bibr" rid="B11">11,</xref><xref ref-type="bibr" rid="B15">15,</xref><xref ref-type="bibr" rid="B17">17,</xref><xref ref-type="bibr" rid="B19">19,</xref><xref ref-type="bibr" rid="B22">22,</xref><sup>[<xref ref-type="bibr" rid="B23">23</xref>]</sup> from pancreatic cancer, both modalities are poor in detecting nodal metastases<sup>[<xref ref-type="bibr" rid="B30">30</xref>]</sup>.</p></sec><sec><title>Perivascular tumor infiltration</title><p>The probability of tumor invasion of the major peripancreatic vasculature was studied by Lu <italic>et al</italic>.<sup>[<xref ref-type="bibr" rid="B31">31</xref>]</sup> and O&#x02019;Malley <italic>et al</italic>.<sup>[<xref ref-type="bibr" rid="B32">32</xref>]</sup> with helical CT by measuring the degree and extent of tumor&#x02013;vessel contact. Both these studies showed that when tumor&#x02013;vessel contact was less than half the circumference of the vessel, the likelihood of tumor resectability was high (<xref ref-type="fig" rid="F7">Fig. 7</xref>), whereas if it exceeded half the circumference, there was a high probability (80%) of unresectability (<xref ref-type="fig" rid="F8">Fig. 8</xref>). These guidelines for vascular invasion are still in use today although no recent larger studies have been performed to further validate these criteria<sup>[<xref ref-type="bibr" rid="B33 B34 B35">33&#x02013;35</xref>]</sup>.
<fig id="F7" position="float"><label><italic>Figure 7</italic></label><caption><p><bold>Contrast-enhanced axial CT image shows a tumor in the body of the pancreas with less than 180 degrees of circumferential involvement (arrows) of the superior mesenteric vein. The tumor was resectable at surgery.</bold></p></caption><graphic xlink:href="ci07901007"/></fig>
<fig id="F8" position="float"><label><italic>Figure 8</italic></label><caption><p><bold>Contrast-enhanced axial CT image shows a tumor in the head of the pancreas with more than 180 degrees of circumferential involvement (arrows) of the superior mesenteric vein, indicating unresectability.</bold></p></caption><graphic xlink:href="ci07901008"/></fig></p></sec><sec><title>Pitfalls</title><p>As already mentioned previously, rarely pancreatic adenocarcinomas can be isoattenuating and difficult to detect, and one must rely on the ancillary findings such as bile duct or pancreatic duct obstruction to suspect the presence of a neoplasm. The most common condition that mimics pancreatic carcinoma is pancreatitis either in the form of focal acute or &#x02018;mass-forming&#x02019; pancreatitis<sup>[<xref ref-type="bibr" rid="B36 B38">36&#x02013;38</xref>]</sup> (<xref ref-type="fig" rid="F9">Fig. 9</xref>) or chronic pancreatitis. Focal fatty infiltration of the head of the pancreas or focal sparing of fatty infiltration can mimic pancreatic carcinoma. In these situations, MRI is very helpful in excluding pancreatic carcinoma.
<fig id="F9" position="float"><label><italic>Figure 9</italic></label><caption><p><bold>Contrast-enhanced axial CT image shows a mass in the tail of the pancreas (arrow), which at surgery proved to represent acute focal pancreatitis.</bold></p></caption><graphic xlink:href="ci07901009"/></fig></p></sec></body><back><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balci</surname><given-names>NC</given-names></name><name><surname>Semelka</surname><given-names>RC</given-names></name></person-group><article-title>Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma</article-title><source>Eur J Radiol</source><year>2001</year><volume>38</volume><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">11335092</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulig</surname><given-names>J</given-names></name><name><surname>Popiela</surname><given-names>T</given-names></name><name><surname>Zajac</surname><given-names>A</given-names></name><name><surname>Klek</surname><given-names>S</given-names></name><name><surname>Kolodziejczyk</surname><given-names>P</given-names></name></person-group><article-title>The value of imaging techniques in the staging of pancreatic cancer</article-title><source>Surg Endosc</source><year>2005</year><volume>19</volume><fpage>361</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15578251</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takhar</surname><given-names>AS</given-names></name><name><surname>Palaniappan</surname><given-names>P</given-names></name><name><surname>Dhingsa</surname><given-names>R</given-names></name><name><surname>Lobo</surname><given-names>DN</given-names></name></person-group><article-title>Recent developments in diagnosis of pancreatic cancer</article-title><source>BMJ</source><year>2004</year><volume>329</volume><fpage>668</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">15374918</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>DL</given-names></name><name><surname>Thomson</surname><given-names>SR</given-names></name><name><surname>Madiba</surname><given-names>TE</given-names></name><name><surname>Sanyika</surname><given-names>C</given-names></name></person-group><article-title>Preoperative imaging of pancreatic cancer: a management-oriented approach</article-title><source>J Am Coll Surg</source><year>2003</year><volume>196</volume><fpage>119</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">12517564</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schima</surname><given-names>W</given-names></name><name><surname>Ba-Ssalamah</surname><given-names>A</given-names></name><name><surname>K&#x000f6;lblinger</surname><given-names>C</given-names></name><name><surname>Kulinna-Cosentini</surname><given-names>C</given-names></name><name><surname>Puespoek</surname><given-names>A</given-names></name><name><surname>G&#x000f6;tzinger</surname><given-names>P</given-names></name></person-group><article-title>Pancreatic adenocarcinoma</article-title><source>Eur Radiol</source><year>2007</year><volume>17</volume><fpage>638</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">17021700</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeny</surname><given-names>PC</given-names></name><name><surname>Traverso</surname><given-names>LW</given-names></name><name><surname>Ryan</surname><given-names>JA</given-names></name></person-group><article-title>Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography</article-title><source>Am J Surg</source><year>1993</year><volume>165</volume><fpage>600</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8488945</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohn</surname><given-names>TA</given-names></name><name><surname>Yeo</surname><given-names>CJ</given-names></name><name><surname>Cameron</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Resected adenocarcinoma of the pancreas: 616 patients: results, outcomes, and prognostic indications</article-title><source>J Gastrointest Surg</source><year>2000</year><volume>4</volume><fpage>567</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">11307091</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>DS</given-names></name><name><surname>Vedantham</surname><given-names>S</given-names></name><name><surname>Krasny</surname><given-names>J</given-names></name><etal/></person-group><article-title>Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas and vascular structures</article-title><source>Radiology</source><year>1996</year><volume>199</volume><fpage>697</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">8637990</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNulty</surname><given-names>NJ</given-names></name><name><surname>Francis</surname><given-names>IR</given-names></name><name><surname>Platt</surname><given-names>JF</given-names></name><name><surname>Cohan</surname><given-names>RH</given-names></name><name><surname>Korobkin</surname><given-names>M</given-names></name><name><surname>Gebramaniam</surname><given-names>A</given-names></name></person-group><article-title>Multidetector-row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma</article-title><source>Radiology</source><year>2001</year><volume>220</volume><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">11425979</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>JG</given-names></name><name><surname>Wiersma</surname><given-names>MJ</given-names></name><name><surname>Farrell</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Pancreatic malignancy: value of arterial, pancreatic parenchymal and hepatic phase imaging with multidetector-row CT</article-title><source>Radiology</source><year>2003</year><volume>229</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">14519871</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prokesch</surname><given-names>RW</given-names></name><name><surname>Chow</surname><given-names>LC</given-names></name><name><surname>Beaulier</surname><given-names>CF</given-names></name><etal/></person-group><article-title>Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations-initial experience</article-title><source>Radiology</source><year>2002</year><volume>225</volume><fpage>759</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">12461258</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>R</given-names></name><name><surname>Nino-Murica</surname><given-names>M</given-names></name><name><surname>Trueblood</surname><given-names>W</given-names></name><name><surname>Jeffery</surname><given-names>RBJ</given-names></name></person-group><article-title>MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations</article-title><source>AJR</source><year>2004</year><volume>182</volume><fpage>419</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">14736675</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichikawa</surname><given-names>T</given-names></name><name><surname>Erturk</surname><given-names>WM</given-names></name><name><surname>Sou</surname><given-names>H</given-names></name><etal/></person-group><article-title>MDCT of pancreatic adenocarcinoma: optimal imaging phases and multiplanar reformatted imaging</article-title><source>AJR</source><year>2006</year><volume>187</volume><fpage>1513</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">17114545</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukushima</surname><given-names>H</given-names></name><name><surname>Itoh</surname><given-names>S</given-names></name><name><surname>Takada</surname><given-names>A</given-names></name><etal/></person-group><article-title>Diagnostic value of curved multiplanar reformatted images in multislice CT for the detection of resectable pancreatic ductal adenocarcinoma</article-title><source>Eur Radiol</source><year>2006</year><volume>16</volume><fpage>1709</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">16550353</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeny</surname><given-names>PC</given-names></name></person-group><article-title>CT diagnosis and staging of pancreatic carcinoma</article-title><source>Eur Radiol</source><year>2005</year><volume>15</volume><issue>Suppl 4</issue><fpage>D96</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16479656</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronstein</surname><given-names>YL</given-names></name><name><surname>Loyer</surname><given-names>EM</given-names></name><name><surname>Kaur</surname><given-names>H</given-names></name><etal/></person-group><article-title>Detection of small pancreatic tumors with multiphasic helical CT</article-title><source>AJR</source><year>2004</year><volume>182</volume><fpage>619</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">14975959</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SL</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Rae</surname><given-names>DM</given-names></name><name><surname>Sinclair</surname><given-names>M</given-names></name></person-group><article-title>Preoperative staging accuracy of multidetector computed tomography in pancreatic head adenocarcinoma</article-title><source>Pancreas</source><year>2007</year><volume>34</volume><fpage>180</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">17312455</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>MB</given-names></name><name><surname>Ward</surname><given-names>J</given-names></name><name><surname>Guthrie</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis</article-title><source>AJR</source><year>1999</year><volume>173</volume><fpage>583</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">10470884</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>JA</given-names></name><name><surname>Ward</surname><given-names>J</given-names></name><name><surname>Guthrie</surname><given-names>JA</given-names></name><name><surname>Guillou</surname><given-names>PJ</given-names></name><name><surname>Robinson</surname><given-names>PJ</given-names></name></person-group><article-title>Assessment of resectability of pancreatic cancer with dynamic contrast-enhanced MR imaging: technique, surgical correlation and patient outcome</article-title><source>Eur Radiol</source><year>1998</year><volume>8</volume><fpage>23</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9442123</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ly</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>GH</given-names></name></person-group><article-title>MR imaging of the pancreas: a practical approach</article-title><source>Radiol Clin North Am</source><year>2002</year><volume>40</volume><fpage>1289</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">12479712</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erturk</surname><given-names>SM</given-names></name><name><surname>Ichikawa</surname><given-names>T</given-names></name><name><surname>Sou</surname><given-names>H</given-names></name><etal/></person-group><article-title>Pancreatic adenocarcinoma: MDCT versus MRI in the detection and assessment of locoregional extension</article-title><source>J Comput Assist Tomogr</source><year>2006</year><volume>30</volume><fpage>583</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">16845288</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>HE</given-names></name><name><surname>Amthauer</surname><given-names>H</given-names></name><name><surname>Hosten</surname><given-names>N</given-names></name><etal/></person-group><article-title>Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography</article-title><source>Radiology</source><year>2002</year><volume>224</volume><fpage>34</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">12091659</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schima</surname><given-names>W</given-names></name><name><surname>F&#x003cb;gger</surname><given-names>R</given-names></name><name><surname>Schober</surname><given-names>E</given-names></name><etal/></person-group><article-title>Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT</article-title><source>AJR</source><year>2002</year><volume>179</volume><fpage>717</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">12185052</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obuz</surname><given-names>F</given-names></name><name><surname>Dicle</surname><given-names>O</given-names></name><name><surname>Coker</surname><given-names>A</given-names></name><name><surname>Sagol</surname><given-names>O</given-names></name><name><surname>Karademir</surname><given-names>S</given-names></name></person-group><article-title>Pancreatic adenocarcinoma: Detection and staging with dynamic MR imaging</article-title><source>Eur J Radiol</source><year>2001</year><volume>38</volume><fpage>146</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">11335097</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>FH</given-names></name><name><surname>Rini</surname><given-names>NJ</given-names></name><name><surname>Keppke</surname><given-names>AL</given-names></name></person-group><article-title>MRI of adenocarcinoma of the pancreas</article-title><source>AJR</source><year>2006</year><volume>187</volume><fpage>W365</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">16985107</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewitt</surname><given-names>J</given-names></name><name><surname>Deveraux</surname><given-names>B</given-names></name><name><surname>Chriswell</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer</article-title><source>Ann Intern Med</source><year>2004</year><volume>141</volume><fpage>753</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">15545675</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soriano</surname><given-names>A</given-names></name><name><surname>Castells</surname><given-names>A</given-names></name><name><surname>Ayuso</surname><given-names>C</given-names></name><etal/></person-group><article-title>Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography</article-title><source>Am J Gastroenterol</source><year>2004</year><volume>99</volume><fpage>492</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">15056091</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeWitt</surname><given-names>J</given-names></name><name><surname>Devereaux</surname><given-names>B</given-names></name><name><surname>Chriswell</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer</article-title><source>Am Coll Phys</source><year>2004</year><volume>141</volume><fpage>753</fpage><lpage>63</lpage></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeman</surname><given-names>RK</given-names></name><name><surname>Cooper</surname><given-names>C</given-names></name><name><surname>Zeiberg</surname><given-names>AS</given-names></name><etal/></person-group><article-title>TNM staging of pancreatic carcinoma using helical CT</article-title><source>AJR</source><year>1997</year><volume>169</volume><fpage>459</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">9242754</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roche</surname><given-names>CJ</given-names></name><name><surname>Hughes</surname><given-names>ML</given-names></name><name><surname>Garvey</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas</article-title><source>AJR</source><year>2003</year><volume>180</volume><fpage>475</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">12540455</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>DS</given-names></name><name><surname>Reber</surname><given-names>HA</given-names></name><name><surname>Krasny</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic phase thin-section helical CT</article-title><source>AJR</source><year>1997</year><volume>168</volume><fpage>1439</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">9168704</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Malley</surname></name><name><surname>Boland</surname><given-names>GW</given-names></name><name><surname>Wood</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT</article-title><source>AJR</source><year>1999</year><volume>173</volume><fpage>1513</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">10584794</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phoa</surname><given-names>SS</given-names></name><name><surname>Reeders</surname><given-names>JW</given-names></name><name><surname>Stoker</surname><given-names>J</given-names></name><etal/></person-group><article-title>CT criteria for venous invasion in patients with pancreatic head carcinoma</article-title><source>Br J Radiol</source><year>2000</year><volume>73</volume><fpage>1159</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">11144792</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horton</surname><given-names>KM</given-names></name><name><surname>Fishman</surname><given-names>EK</given-names></name></person-group><article-title>Multidetector CT angiography of pancreatic carcinoma: Part I, Evaluation of arterial involvement</article-title><source>AJR</source><year>2002</year><volume>178</volume><fpage>827</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11906856</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horton</surname><given-names>KM</given-names></name><name><surname>Fishman</surname><given-names>EK</given-names></name></person-group><article-title>Multidetector CT angiography of pancreatic carcinoma: Part II, Evaluation of arterial involvement</article-title><source>AJR</source><year>2002</year><volume>178</volume><fpage>833</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11906858</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balthazar</surname><given-names>EJ</given-names></name></person-group><article-title>Pancreatitis associated with pancreatic carcinoma. preoperative diagnosis: role of CT imaging in detection and evaluation</article-title><source>Pancreatology</source><year>2005</year><volume>5</volume><fpage>330</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">16015017</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oto</surname><given-names>A</given-names></name><name><surname>Eltorky</surname><given-names>MA</given-names></name><name><surname>Dave</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mimicks of pancreatic malignancy in patients with chronic pancreatitis: Correlation of computed tomography imaging features with histopathologic findings</article-title><source>Curr Probl Diagn Radiol</source><year>2006</year><volume>35</volume><fpage>199</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">16949476</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>PT</given-names></name><name><surname>Outwater</surname><given-names>EK</given-names></name></person-group><article-title>Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging</article-title><source>Radiology</source><year>1999</year><volume>212</volume><fpage>213</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">10405744</pub-id></element-citation></ref></ref-list></back></article>